CA Patent

CA2551946A1 — Immediate, controlled and sustained release formulations of galantamine

Assigned to Actavis Group hf · Expires 2005-07-21 · 21y expired

What this patent protects

Galantamine formulations, including sustained-release and fast dissolve formulations, are described.

USPTO Abstract

Galantamine formulations, including sustained-release and fast dissolve formulations, are described.

Drugs covered by this patent

oxycodone-hydrochloride (OXYCODONE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2551946A1
Jurisdiction: CA
Classification: —
Expires: 2005-07-21
Drug substance claim: No
Drug product claim: No
Assignee: Actavis Group hf
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.